{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:13:33Z","timestamp":1784121213419,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T00:00:00Z","timestamp":1410912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10067-014-2783-z","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T02:26:15Z","timestamp":1410834375000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Management of gout in general practice\u2014a systematic review"],"prefix":"10.1007","volume":"34","author":[{"given":"Andrew","family":"Jeyaruban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Larkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Soden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"issue":"11","key":"2783_CR1","first-page":"2403","volume":"29","author":"E Arromdee","year":"2002","unstructured":"Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? The J Rheumatol 29(11):2403\u20132406","journal-title":"The J Rheumatol"},{"issue":"1","key":"2783_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/ard.56.1.22","volume":"56","author":"P Klemp","year":"1997","unstructured":"Klemp P, Stansfield SA, Castle B, Robertson MC (1997) Gout is on the increase in New Zealand. Ann Rheum Dis 56(1):22\u201326","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2783_CR3","first-page":"147","volume":"101","author":"D Owens","year":"2008","unstructured":"Owens D, Whelan B, McCarthy G (2008) A survey of the management of gout in primary care. Ir Med J 101(5):147\u2013149","journal-title":"Ir Med J"},{"issue":"1","key":"2783_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrrheum.2009.236","volume":"6","author":"R Terkeltaub","year":"2010","unstructured":"Terkeltaub R (2010) Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 6(1):30\u201338","journal-title":"Nat Rev Rheumatol"},{"key":"2783_CR5","unstructured":"Gout. Therapeutic Guidelines. 2010"},{"issue":"10","key":"2783_CR6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65(10):1312\u20131324","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2783_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1440-1762.2000.00353.x","volume":"20","author":"P Smith","year":"2000","unstructured":"Smith P, Karlson N, Nair BR (2000) Quality use of allopurinol in the elderly. J Qual Clin Pract 20(1):42\u201343","journal-title":"J Qual Clin Pract"},{"issue":"1006","key":"2783_CR8","first-page":"346","volume":"108","author":"AD McClintock","year":"1995","unstructured":"McClintock AD, Egan AJ, Woods DJ, Pillans PI (1995) A survey of allopurinol dosage prescribing. The NZ Medical J 108(1006):346\u2013347","journal-title":"The NZ Medical J"},{"issue":"1","key":"2783_CR9","first-page":"104","volume":"33","author":"T Neogi","year":"2006","unstructured":"Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y (2006) Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. The J Rheumatol 33(1):104\u2013109","journal-title":"The J Rheumatol"},{"issue":"5","key":"2783_CR10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336\u2013341","journal-title":"Int J Surg"},{"issue":"4","key":"2783_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1742395310378761","volume":"6","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA (2010) Patients and providers view gout differently: a qualitative study. Chronic Illness 6(4):263\u2013271","journal-title":"Chronic Illness"},{"key":"2783_CR12","doi-asserted-by":"crossref","unstructured":"M; T, k M (2013) Gouty arthritis: an approach for general practice. South African Family Practice;55 (4)","DOI":"10.1080\/20786204.2013.10874366"},{"issue":"10","key":"2783_CR13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2007.078469","volume":"66","author":"E Pascual","year":"2007","unstructured":"Pascual E, Sivera F (2007) Why is gout so poorly managed? Ann Rheum Dis 66(10):1269\u20131270","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2783_CR14","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/rheumatology\/keq143","volume":"49","author":"ME Perry","year":"2010","unstructured":"Perry ME, Madhok R (2010) Treatment failure gout: failure to treat? Rheumatology 49(12):2233\u20132234","journal-title":"Rheumatology"},{"issue":"1","key":"2783_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-277X.2008.00928.x","volume":"22","author":"P Shulten","year":"2009","unstructured":"Shulten P, Thomas J, Miller M, Smith M, Ahern M (2009) The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Human Nutr and Diet : The Off J The Br Diet Asso 22(1):3\u201311","journal-title":"J Human Nutr and Diet : The Off J The Br Diet Asso"},{"issue":"6","key":"2783_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.reuma.2012.05.008","volume":"8","author":"N Fara","year":"2012","unstructured":"Fara N, Vazquez Mellado J, Sequeira G, Kerzberg E (2012) A survey on the current evaluation and treatment of gout in Buenos Aires. Argent Reumatol Clin 8(6):306\u2013309","journal-title":"Argent Reumatol Clin"},{"issue":"302","key":"2783_CR17","first-page":"409","volume":"37","author":"RC Fraser","year":"1987","unstructured":"Fraser RC, Davis RH, Walker FS (1987) Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia. The J The R Coll Gen Pract 37(302):409\u2013411","journal-title":"The J The R Coll Gen Pract"},{"issue":"4","key":"2783_CR18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.080768","volume":"36","author":"JG Hanly","year":"2009","unstructured":"Hanly JG, Skedgel C, Sketris I, Cooke C, Linehan T, Thompson K et al (2009) Gout in the elderly\u2014a population health study. The J Rheumatol 36(4):822\u2013830","journal-title":"The J Rheumatol"},{"key":"2783_CR19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2474-13-180","volume":"13","author":"LR Harrold","year":"2012","unstructured":"Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood RA (2012) Patients\u2019 knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord 13:180","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"2783_CR20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00124743-199702000-00005","volume":"3","author":"MV Medellin","year":"1997","unstructured":"Medellin MV, Erickson AR, Enzenauer RJ (1997) Variability of treatment for gouty arthritis between rheumatologists and primary care physicians. J Clin Rheumatol: Pract Rep on Rheum & Musculoskelet Dis 3(1):24\u201327","journal-title":"J Clin Rheumatol: Pract Rep on Rheum & Musculoskelet Dis"},{"issue":"1","key":"2783_CR21","doi-asserted-by":"crossref","first-page":"e003627","DOI":"10.1136\/bmjopen-2013-003627","volume":"4","author":"RD Goldfien","year":"2014","unstructured":"Goldfien RD, Ng MS, Yip G, Hwe A, Jacobson A, Pressman A et al (2014) Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study. BMJ Open 4(1):e003627","journal-title":"BMJ Open"},{"issue":"2","key":"2783_CR22","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar3272","volume":"13","author":"L Cea Soriano","year":"2011","unstructured":"Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA (2011) Contemporary epidemiology of gout in the UK general population. Arthritis Res & Ther 13(2):R39","journal-title":"Arthritis Res & Ther"},{"issue":"1","key":"2783_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjmed.2009.05.026","volume":"123","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Andrade SE, Briesacher B, Raebel MA, Fouayzi H, Yood RA et al (2010) The dynamics of chronic gout treatment: medication gaps and return to therapy. The Am J Med 123(1):54\u201359","journal-title":"The Am J Med"},{"issue":"2","key":"2783_CR24","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","volume":"11","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA et al (2009) Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res & Ther 11(2):R46","journal-title":"Arthritis Res & Ther"},{"issue":"15","key":"2783_CR25","first-page":"435","volume":"11","author":"AJ Luk","year":"2005","unstructured":"Luk AJ, Simkin PA (2005) Epidemiology of hyperuricemia and gout. The Am J Manag Care 11(15):435\u2013442, quiz S65-8","journal-title":"The Am J Manag Care"},{"issue":"7","key":"2783_CR26","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis 67(7):960\u2013966","journal-title":"Ann Rheum Dis"},{"key":"2783_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2296-14-170","volume":"14","author":"E Cottrell","year":"2013","unstructured":"Cottrell E, Crabtree V, Edwards JJ, Roddy E (2013) Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pract 14:170","journal-title":"BMC Fam Pract"},{"issue":"10","key":"2783_CR28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/ard.2006.051649","volume":"65","author":"LR Harrold","year":"2006","unstructured":"Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J et al (2006) Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis 65(10):1368\u20131372","journal-title":"Ann Rheum Dis"},{"key":"2783_CR29","doi-asserted-by":"crossref","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2014) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Annals of the rheumatic diseases","DOI":"10.1136\/annrheumdis-2013-204463"},{"issue":"8","key":"2783_CR30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","volume":"44","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG (2005) Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK general practice research database (GPRD). Rheumatology 44(8):1038\u20131042","journal-title":"Rheumatology"},{"issue":"2","key":"2783_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK general practice research database, 1990\u20131999. Ann Rheum Dis 64(2):267\u2013272","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2783_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/kep332","volume":"49","author":"E Roddy","year":"2010","unstructured":"Roddy E, Mallen CD, Hider SL, Jordan KP (2010) Prescription and comorbidity screening following consultation for acute gout in primary care. Rheumatology 49(1):105\u2013111","journal-title":"Rheumatology"},{"issue":"5","key":"2783_CR33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM (2007) Quality of care for gout in the US needs improvement. Arthritis Rheum 57(5):822\u2013829","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2783_CR34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/ard.2007.070755","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M (2007) Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 66(10):1311\u20131315","journal-title":"Ann Rheum Dis"},{"key":"2783_CR35","volume-title":"Oxmis problem code for primary care","author":"J Perry","year":"1971","unstructured":"Perry J (1971) Oxmis problem code for primary care. Oxmis Publications, Oxford"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2783-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2783-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2783-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:44:06Z","timestamp":1565829846000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2783-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2783"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2783-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}